Cure My Disease

Don't miss your cure!

 Log in / Sign up

Timing your meals: a new weapon against diabetes?

NCT ID NCT07171281

Recruiting now Symptom relief Sponsor: German Institute of Human Nutrition Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether eating all meals within an early 8-hour window (and cutting calories by 25%) can improve blood sugar and heart health in people who are overweight and have prediabetes, type 2 diabetes, or normal blood sugar. Thirty participants will try either early or late time-restricted eating for several weeks. The goal is to see if meal timing matters beyond just calorie reduction.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
time-restricted eating (early vs. late eating window)
What this could lead to
If it works, this could point toward a simple, drug-free way to improve blood sugar control and reduce heart disease risk in people with prediabetes or type 2 diabetes.
What could go wrong
This is a small, early-stage trial with only 30 participants, so results may not apply to everyone. The strict eating schedule and calorie reduction may be hard to maintain long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Intermittent Fasting Obesity obesity disorder Overweight prediabetes syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY & OVERWEIGHT PREDIABETES TYPE 2 DIABETES

Contacts and locations

Locations

  • German Institute of Human Nutrition Potsdam-Rehbruecke

    RECRUITING

    Nuthetal, 14558, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.